618 related articles for article (PubMed ID: 22941261)
1. Autoimmune mechanisms in myasthenia gravis.
Cavalcante P; Bernasconi P; Mantegazza R
Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
[TBL] [Abstract][Full Text] [Related]
2. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia and the neuromuscular junction.
Gilhus NE
Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis and the neuromuscular junction.
Querol L; Illa I
Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
Baggi F; Antozzi C; Toscani C; Cordiglieri C
Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
Le Panse R; Berrih-Aknin S
Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
[TBL] [Abstract][Full Text] [Related]
7. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
[TBL] [Abstract][Full Text] [Related]
9. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
Ohta R; Motomura M
Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
Higuchi O; Hamuro J; Motomura M; Yamanashi Y
Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
[TBL] [Abstract][Full Text] [Related]
11. Insights in the autoimmunity of myasthenia gravis.
De Baets MH
Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.
Huijbers MG; Lipka AF; Plomp JJ; Niks EH; van der Maarel SM; Verschuuren JJ
J Intern Med; 2014 Jan; 275(1):12-26. PubMed ID: 24215230
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects.
Abramsky O
Int J Neurol; 1980; 14(1):25-34. PubMed ID: 6293989
[No Abstract] [Full Text] [Related]
14. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis: from autoantibodies to therapy.
Mantegazza R; Bernasconi P; Cavalcante P
Curr Opin Neurol; 2018 Oct; 31(5):517-525. PubMed ID: 30156572
[TBL] [Abstract][Full Text] [Related]
16. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
Hohlfeld R; Wekerle H
MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
18. Etiology of myasthenia gravis: innate immunity signature in pathological thymus.
Cavalcante P; Cufi P; Mantegazza R; Berrih-Aknin S; Bernasconi P; Le Panse R
Autoimmun Rev; 2013 Jul; 12(9):863-74. PubMed ID: 23535157
[TBL] [Abstract][Full Text] [Related]
19. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.
Shen C; Lu Y; Zhang B; Figueiredo D; Bean J; Jung J; Wu H; Barik A; Yin DM; Xiong WC; Mei L
J Clin Invest; 2013 Dec; 123(12):5190-202. PubMed ID: 24200689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
